Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation

MeSH terms

• Aged
• Anticoagulants* / administration & dosage
• Anticoagulants* / adverse effects
• Anticoagulants* / classification
• Atrial Fibrillation / drug therapy*
• Atrial Fibrillation / etiology
• Cardiomyopathy, Hypertrophic* / complications
• Cardiomyopathy, Hypertrophic* / epidemiology
• Female
• Hemorrhage* / chemically induced
• Hemorrhage* / epidemiology
• Humans
• Incidence
• Insurance Claim Review / statistics & numerical data
• Male
• Middle Aged
• Risk Adjustment / methods
• Stroke* / epidemiology
• Stroke* / etiology
• Stroke* / prevention & control
• United States / epidemiology